The transcription factor Sox2 is required for osteoblast self-renewal
Open Access
- 21 May 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Differentiation
- Vol. 17 (8), 1345-1353
- https://doi.org/10.1038/cdd.2010.57
Abstract
The development and maintenance of most tissues and organs require the presence of multipotent and unipotent stem cells that have the ability of self-renewal as well as of generating committed, further differentiated cell types. The transcription factor Sox2 is essential for embryonic development and maintains pluripotency and self-renewal in embryonic stem cells. It is expressed in immature osteoblasts/osteoprogenitors in vitro and in vivo and is induced by fibroblast growth factor signaling, which stimulates osteoblast proliferation and inhibits differentiation. Sox2 overexpression can by itself inhibit osteoblast differentiation. To elucidate its function in the osteoblastic lineage, we generated mice with an osteoblast-specific, Cre-mediated knockout of Sox2. These mice are small and osteopenic, and mosaic for Sox2 inactivation. However, culturing calvarial osteoblasts from the mutant mice for 2–3 passages failed to yield any Sox2-null cells. Inactivation of the Sox2 gene by Cre-mediated excision in cultured osteoblasts showed that Sox2-null cells could not survive repeated passage in culture, could not form colonies, and arrested their growth with a senescent phenotype. In addition, expression of Sox2-specific shRNAs in independent osteoblastic cell lines suppressed their proliferative ability. Osteoblasts capable of forming ‘osteospheres’ are greatly enriched in Sox2 expression. These data identify a novel function for Sox2 in the maintenance of self-renewal in the osteoblastic lineage.Keywords
This publication has 40 references indexed in Scilit:
- Impaired bone development and increased mesenchymal progenitor cells in calvaria of RB1 −/− miceProceedings of the National Academy of Sciences of the United States of America, 2008
- DLX5 overexpression impairs osteogenic differentiation of human bone marrow stromal cellsEuropean Journal of Cell Biology, 2008
- Fibroblast Growth Factor Signaling Uses Multiple Mechanisms To Inhibit Wnt-Induced Transcription in OsteoblastsMolecular and Cellular Biology, 2008
- Forced expression of Sox2 or Nanog in human bone marrow derived mesenchymal stem cells maintains their expansion and differentiation capabilitiesExperimental Cell Research, 2008
- Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potentialProceedings of the National Academy of Sciences of the United States of America, 2007
- Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathwaysJournal of Cellular Physiology, 2007
- Multiple dose-dependent roles for Sox2 in the patterning and differentiation of anterior foregut endodermDevelopment, 2007
- Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factorsThe International Journal of Biochemistry & Cell Biology, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- SOX2 is a dose-dependent regulator of retinal neural progenitor competenceGenes & Development, 2006